May 13, 2021With the increasing application of iodinated contrast agents, the adverse reactions and risks caused by iodinated contrast agents have attracted much attention.view
February 24, 2023Recently, the "Wealth and Responsibility - Values of Enterprises" 2022 China Top 500 Charity List Conference was held in Chongqing. Since its inclusion in 2021, Beilu Pharmaceutical has been...view
April 11, 2025Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the "Marketing Authorization" (MA) issued by the Netherlands Medicines Evaluation Board (MEB) in accordance with the relevant regula...view
March 22, 2022The integration of "APIs + Injection" is the key layout of Beilu Pharma (300016)'s strategic development in recent years, and the construction of contrast agent APIs is one of the compan...view
September 9, 2024Iodixanol is the active pharmaceutical ingredient for iodixanol injection, a contrast agent used for intrathecal contrast, cardiovascular angiography, and intravenous urography. Its mechanism of actio...view
June 20, 2023The company's product, Jiuwei Zhenxin Granules, has been included in the "Expert Consensus on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Bipolar Depression...view